Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaniaga BhdXKLS:7081 45 Interest Coverage is 5.46 as of Mar. 2026, which is 78% above its 10-year median of 3.07. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.73 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 89 Medical Distribution companies, Pharmaniaga Bhd ranks worse than 83.15% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Pharmaniaga Bhd's
Operating Income
for the
three
months ended in Mar. 2026 was RM55 Mil. Pharmaniaga Bhd's Interest Expense for the
three
months ended in Mar. 2026 was RM-10 Mil.
Pharmaniaga Bhd's interest coverage for the quarter that ended in Mar. 2026 was 5.46.
The higher the ratio, the stronger the company's financial strength is.
Warning Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Pharmaniaga Bhd interest coverage is 2.29, which is low.
The historical rank and industry rank for Pharmaniaga Bhd's Interest Coverage or its related term are showing as below:
XKLS:7081'
s Interest Coverage Range Over the Past 10 Years
Min: 2.02 Med: 3.07 Max: 9.23
Current: 2.29
XKLS:7081's Interest Coverage is ranked worse than 83.15% of 89
companies
in the Medical Distribution industry
Industry Median: 6.23
vs XKLS:7081: 2.29
Pharmaniaga Bhd (XKLS:7081) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Pharmaniaga Bhd Interest Coverage Related Terms
Pharmaniaga Bhd Interest Coverage Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XKLS:7081 vs MCK, CAH, COR: Interest Coverage Comparison
For the Medical Distribution subindustry, Pharmaniaga Bhd's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a Interest Coverage of 5.46 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pharmaniaga Bhd and its competitors. This is 78% above median its historical median of 3.07. Over the past decade, Pharmaniaga Bhd's Interest Coverage has ranged from 2.02 to 9.23. According to the industry distribution chart, Pharmaniaga Bhd ranks #74 out of 89 companies in the Medical Distribution industry, placing it in the top 83.1%.
Is Pharmaniaga Bhd's Interest Coverage too high?
Pharmaniaga Bhd's current Interest Coverage of 5.46 is 78% above median its 10-year median of 3.07. Over the past 10 years, this metric has ranged from a low of 2.02 to a high of 9.23. The Medical Distribution industry median Interest Coverage is 6.23. Pharmaniaga Bhd's value of 5.46 is 12.4% below this industry median. Based on the distribution chart, Pharmaniaga Bhd ranks #74 out of 89 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's Interest Coverage compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #74 out of 89 companies for Interest Coverage. This places Pharmaniaga Bhd in the lower half of its industry. The industry median Interest Coverage is 6.23. Pharmaniaga Bhd's value of 5.46 is 12.4% below this benchmark. Historically, Pharmaniaga Bhd's own Interest Coverage has ranged from 2.02 to 9.23 over the past decade. While the company's 10-year median is 3.07 vs. the industry median of 6.23, Pharmaniaga Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharmaniaga Bhd's current Interest Coverage of 5.46 is 12.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current Interest Coverage is 5.46, which is 78% above median its own 10-year median of 3.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current Interest Coverage is 5.46, which is 78% above median its 10-year median of 3.07 and 12.4% below the Medical Distribution industry median of 6.23. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current Interest Coverage is 5.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
Interest Coverage: 5.46 (78% above median its 10-year median of 3.07)
GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
Industry Position: 12.4% below the Medical Distribution median (#74 of 89)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score
Get the complete analysis for XKLS:7081
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
